EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Benzinga (Fri, 3-Jan 1:28 PM ET)
AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market
PRNewswire (Mon, 21-Oct 4:27 PM ET)
The Fund is an actively managed exchange-traded fund ( ETF ) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. The Fund primarily will invest in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies.In addition to its investment in securities of companies that derive a significant portion of their revenue from the marijuana and hemp business, and in derivatives providing exposure to such securities, the Fund may invest in securities of companies that, in the opinion of the Advisor, may have current or future revenues from cannabis-related business or that are registered with the DEA specifically for the purpose of handling marijuana for lawful research and development of cannabis or cannabinoid-related products.
Advisorshares Trust Advisorshares Pure US Cannabis ETF trades on the ARCA stock market under the symbol MSOS.
As of January 8, 2025, MSOS stock price declined to $3.63 with 3,099,924 million shares trading.
MSOS has a beta of -0.43, meaning it tends to be less sensitive to market movements. MSOS has a correlation of 0.01 to the broad based SPY ETF.
MSOS has a market cap of $473.99 million. This is considered a Small Cap stock.
In the last 3 years, MSOS traded as high as $25.63 and as low as $3.42.
MSOS has underperformed the market in the last year with a return of -54.1%, while the SPY ETF gained +26.9%. In the last 3 month period, MSOS fell short of the market, returning -47.2%, while SPY returned +3.7%. However, in the most recent 2 weeks MSOS has outperformed the stock market by returning -1.4%, while SPY returned -2.4%.
MSOS support price is $3.73 and resistance is $4.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MSOS shares will trade within this expected range on the day.